
    
      This is a Manocept Platform prospective, open-label, multicenter, single and repeat-dose
      study designed to evaluate the reliability and sensitivity of TUV assessments in HCs and
      subjects with active RA.

      This study is stratified into 3 arms. The first 2 arms, comprised of [1] disease-free HCs and
      [2] clinically diagnosed RA subjects on stable treatment. The third arm is designed to assess
      the efficacy of TUV global in clinically diagnosed subjects with active RA..
    
  